A Different Immunologic Profile Characterizes Patients With HER-2-overexpressing and HER-2-negative Locally Advanced Breast Cancer: Implications for Immune-Based Therapies
Breast Cancer Research - United Kingdom
doi 10.1186/bcr3060
Full Text
Open PDFAbstract
Available in full text
Date
November 23, 2011
Authors
Publisher
Springer Science and Business Media LLC